Recombinant Archaeoglobus fulgidus Isocitrate dehydrogenase [NADP] (icd)

Shipped with Ice Packs
In Stock

Description

Enzymatic Role and Biological Context

AfIDH is a key enzyme in the tricarboxylic acid (TCA) cycle of Archaeoglobus fulgidus, a hyperthermophilic archaeon thriving in high-temperature environments . This NADP⁺-dependent enzyme ensures metabolic flux toward α-ketoglutarate production while generating NADPH, essential for biosynthetic pathways and redox homeostasis . Unlike bacterial IDHs with dual cofactor specificity (e.g., Methylobacillus flagellatus IDH) , AfIDH exhibits strict NADP⁺ dependency, a feature critical for its role in archaeal metabolism .

Recombinant Expression and Purification

AfIDH was heterologously expressed in Escherichia coli using the pBAD202 vector with a 6x His-tag for purification . Key steps include:

  • Cloning: PCR amplification of the icd2 gene from A. fulgidus genomic DNA, followed by ligation into pBAD202 .

  • Expression: Induced in E. coli Rosetta pRARE under arabinose-promoter control, optimizing codon usage for archaeal genes .

  • Purification: Affinity chromatography via Ni²⁺-NTA resin, yielding active homodimeric enzyme .

Biochemical Characterization

  • pH Optimum: Activity peaks at slightly alkaline pH (8.0–8.5), consistent with stability under archaeal hydrothermal conditions .

  • Thermostability: Retains activity at 50°C, with 50% inactivation after 1 hour at 75°C . Comparable to Clostridium thermocellum IDH (Tm = 67.9°C) .

  • Cation Dependence: Requires Mn²⁺ or Mg²⁺ for activity, mirroring divalent metal dependency in bacterial IDHs .

Functional and Evolutionary Significance

AfIDH’s unique NADP⁺ binding pocket architecture, revealed through comparative modeling, underscores evolutionary trade-offs between cofactor affinity and thermal resilience . Unlike eukaryotic IDHs regulated by phosphorylation (e.g., human isoforms linked to glioblastoma) , archaeal IDHs lack post-translational modifications, relying instead on rigid domain movements for catalysis . This enzyme serves as a model for engineering industrial biocatalysts requiring thermostability and NADPH regeneration capacity.

Research Applications and Future Directions

AfIDH’s recombinant form enables structural studies to elucidate mechanisms of extremophile adaptation. Future work could explore:

  • Directed Evolution: Enhancing NADP⁺ affinity while retaining thermostability.

  • Metabolic Engineering: Integrating AfIDH into synthetic pathways for high-temperature bioprocessing.

  • Comparative Studies: Contrasting locking mechanisms (e.g., Arg-mediated domain interactions) with psychrophilic IDHs like Desulfotalea psychrophila IDH .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with normal blue ice packs by default. For dry ice shipping, contact us in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize its development.
Synonyms
icd; AF_0647; Isocitrate dehydrogenase [NADP]; IDH; EC 1.1.1.42; IDP; NADP(+)-specific ICDH; Oxalosuccinate decarboxylase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-412
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)
Target Names
icd
Target Protein Sequence
MQYEKVKPPE NGEKIRYENG KLIVPDNPII PYFEGDGIGK DVVPAAIRVL DAAADKIGKE VVWFQVYAGE DAYKLYGNYL PDDTLNAIKE FRVALKGPLT TPVGGGYRSL NVTIRQVLDL YANVRPVYYL KGVPSPIKHP EKVNFVIFRE NTEDVYAGIE WPRGSEEALK LIRFLKNEFG VTIREDSGIG IKPISEFATK RLVRMAIRYA IENNRKSVTL VHKGNIMKYT EGAFRDWGYE VAKQEFGEYC ITEDELWDKY GGKQPEGKIV VKDRIADNMF QQILTRTDEY DVIALPNLNG DYLSDAAAAL IGGLGIAPGS NIGDGIGVFE PVHGSAPKYA GQNKVNPTAE ILTGALMFEY IGWKDASEMI KKAVEMTISS GIVTYDIHRH MGGTKVGTRE FAEAVVENLQ SL
Uniprot No.

Q&A

What is Archaeoglobus fulgidus Isocitrate Dehydrogenase and why is it significant for research?

Archaeoglobus fulgidus isocitrate dehydrogenase (AfIDH) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate while reducing NADP+ to NADPH. It is significant for research because of its remarkable thermal stability, with an apparent melting temperature (Tm) of 98.5°C . This hyperthermophilic enzyme provides an excellent model for studying mechanisms of protein thermostability and adaptation to extreme environments. Furthermore, enzymes from extremophiles often exhibit unique structural features that can provide insights into protein evolution and structure-function relationships. AfIDH shows striking similarity to mesophilic IDH from Escherichia coli (EcIDH) despite their different thermal properties, making it valuable for comparative studies .

How is the AfIDH gene typically cloned and expressed in E. coli systems?

While the search results don't provide specific details for AfIDH cloning, we can extrapolate from methods used for other archaeal IDHs. Based on similar approaches used for IDHs from organisms like Haloferax volcanii and Methylobacillus flagellatus, the AfIDH gene can be amplified from genomic DNA using PCR with specific primers designed based on the genome sequence .

For expression, the gene would typically be inserted into expression vectors such as pET series vectors (e.g., pET-15b or pET3a) with an appropriate promoter and affinity tag . The expression construct would then be transformed into E. coli expression strains such as BL21(DE3). Expression is commonly induced by adding IPTG (typically 1 mM) when the culture reaches an OD600 of 0.5-0.6, followed by incubation for several hours (e.g., 3 hours) . It's worth noting that, as observed with other archaeal proteins, AfIDH might form inclusion bodies in E. coli, necessitating refolding procedures to obtain active enzyme .

What are the optimal buffer conditions for maintaining AfIDH stability and activity?

For AfIDH specifically, given its hyperthermophilic origin, buffers that maintain stability at high temperatures would be important. The presence of divalent cations, particularly Mg²⁺ or Mn²⁺, would likely be necessary for optimal activity, as these are common cofactors for IDHs across various organisms . Additionally, reducing agents such as DTT or β-mercaptoethanol might help maintain any critical cysteine residues in a reduced state, preventing oxidation that could lead to activity loss.

What is the most effective purification strategy for recombinant AfIDH?

While the search results don't specify a purification protocol specifically for AfIDH, effective strategies can be inferred from those used for similar archaeal IDHs. A common approach would involve affinity chromatography using a histidine tag, as demonstrated with other recombinant IDHs .

For recombinant AfIDH expressed with a His-tag, the typical purification workflow would include:

  • Cell lysis by sonication in an appropriate buffer

  • Clarification of the lysate by centrifugation (e.g., 12,000× g for 15 min at 4°C)

  • Immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar resin

  • Elution with imidazole gradient or step elution

  • Optional tag removal using an appropriate protease if the tag affects activity

  • Further purification by size exclusion chromatography if needed

If AfIDH forms inclusion bodies (as observed with H. volcanii IDH ), a refolding protocol would be necessary, involving solubilization in denaturants (e.g., 8 M urea) followed by dilution into a refolding buffer containing EDTA, MgCl₂, and potentially NaCl at appropriate concentrations. The refolded enzyme would require incubation time at room temperature or controlled conditions to achieve maximal activity .

How can I assay AfIDH activity and what are the expected kinetic parameters?

The standard assay for IDH activity typically involves monitoring the production of NADPH spectrophotometrically at 340 nm. While specific kinetic parameters for AfIDH aren't provided in the search results, we can infer expected ranges from other characterized IDHs.

Standard Assay Protocol:

  • Reaction buffer: Typically contains Tris-HCl or similar buffer (pH 7.5-8.5)

  • Substrates: DL-isocitrate (variable concentrations for kinetics)

  • Cofactor: NADP⁺ (variable concentrations for kinetics)

  • Divalent cation: Typically Mg²⁺ or Mn²⁺ (1-10 mM)

  • Temperature: For AfIDH, given its thermophilic nature, activity would likely be assayed at elevated temperatures (50-80°C)

Expected Kinetic Parameters:
Based on data from other IDHs, AfIDH might exhibit:

  • Km for isocitrate: likely in the range of 8-50 μM (based on values from other IDHs: 9.0 μM for MfIDH , 45 μM for ClIDH )

  • Km for NADP⁺: likely in the range of 30-200 μM (based on 113 μM for NAD⁺ and 184 μM for NADP⁺ in MfIDH , 27 μM for NADP⁺ in ClIDH )

  • Optimal pH: Likely 7.5-8.5 for the decarboxylation reaction

  • Temperature optimum: Likely 75-95°C, given its high thermal stability (Tm of 98.5°C)

What is the oligomeric structure of AfIDH and how does it compare to IDHs from other organisms?

While the specific oligomeric structure of AfIDH isn't explicitly stated in the search results, we can infer it based on its similarity to E. coli IDH (EcIDH) mentioned in result . AfIDH is likely a homodimer, similar to EcIDH, as the text discusses dimeric interfaces and inter-subunit interactions .

Comparatively, IDHs from different organisms exhibit varying quaternary structures:

  • Most bacterial NADP-dependent IDHs (including E. coli) are homodimers

  • MfIDH from Methylobacillus flagellatus is a homodimer with a subunit molecular mass of 45 kDa

  • IDH from Chlorobium limicola (ClIDH) is a monomeric enzyme of 80 kDa, distinct from the typical dimeric bacterial IDHs

This structural diversity reflects the evolutionary adaptations of IDHs across different taxonomic groups and ecological niches. The dimeric structure of AfIDH likely contributes to its thermostability through specific inter-subunit interactions, including a unique inter-subunit aromatic cluster mentioned in the search results .

What structural features contribute to the exceptional thermostability of AfIDH?

AfIDH exhibits remarkable thermostability with a melting temperature (Tm) of 98.5°C . Several structural features contribute to this property:

  • Unique inter-domain ionic networks: AfIDH contains two distinctive ionic networks not found in mesophilic counterparts:

    • A three-membered ionic network between the large and small domains

    • A four-membered ionic network between the clasp and small domains

  • Clasp domain contributions: The clasp domain appears particularly important for thermostability, as demonstrated by domain swapping experiments. When the clasp domain of AfIDH was replaced with that of E. coli IDH, the Tm decreased by 18°C .

  • Aromatic clusters: A unique aromatic cluster near the N-terminus of AfIDH likely provides additional stabilization to this region. Additionally, an inter-subunit aromatic cluster may strengthen the dimeric interface .

  • Ion pairs and ionic networks: While AfIDH doesn't appear to have more ion pairs than its mesophilic counterpart (EcIDH), the strategic placement and networking of these interactions likely contribute to stability at high temperatures .

These features collectively enhance the structural rigidity of AfIDH at elevated temperatures while maintaining sufficient flexibility for catalytic function.

How does the NADP+ binding site of AfIDH compare to other IDHs with different cofactor specificities?

While the search results don't provide specific details about the NADP⁺ binding site of AfIDH, insights can be drawn from studies of other IDHs with varying cofactor specificities.

The cofactor binding site is a critical determinant of specificity for NAD⁺ versus NADP⁺. In the case of MfIDH, which exhibits dual specificity for both NAD⁺ and NADP⁺, key residues in the coenzyme-binding site (specifically Lys340, Ile341, and Ala347) are implicated in this unusual property .

For NADP⁺-specific IDHs like AfIDH, the binding site typically features:

  • Positively charged residues (like arginine or lysine) that interact with the 2'-phosphate of NADP⁺

  • A binding pocket that accommodates the additional phosphate group of NADP⁺

  • Specific hydrogen bonding networks that favor NADP⁺ over NAD⁺

The N⁶ amino group of the cofactor appears to be indispensable for binding in some IDHs, as demonstrated with MfIDH . For researchers interested in engineering cofactor specificity, these residues would be primary targets for mutagenesis studies.

What role does the clasp domain play in AfIDH function and stability?

The clasp domain of AfIDH plays a crucial role in the enzyme's thermostability. Domain swapping experiments demonstrated that when the clasp domain of AfIDH was replaced with that of E. coli IDH (EcIDH), the melting temperature decreased significantly by 18°C . This indicates that the clasp domain contains key structural elements that contribute to the hyperthermostability of AfIDH.

Specifically, the clasp domain in AfIDH participates in a unique four-membered ionic network with the small domain . This ionic network likely stabilizes the tertiary structure by reinforcing domain interactions at high temperatures. The presence of such interdomain networks appears to be a characteristic feature of thermophilic adaptations in this enzyme family.

Additionally, the reciprocal experiment (replacing the EcIDH clasp with that from AfIDH) only increased EcIDH stability by 4°C, suggesting that the clasp domain functions optimally in the context of the entire AfIDH structure and that thermostability emerges from multiple cooperative interactions across the protein .

How can AfIDH be engineered to alter its cofactor specificity between NAD+ and NADP+?

Engineering AfIDH to alter its cofactor specificity would focus on modifying the coenzyme-binding site, particularly residues that interact with the 2'-phosphate group of NADP⁺. Based on studies of other IDHs, several approaches can be considered:

  • Target residue identification: Analyze the binding pocket residues that differ between NADP⁺-specific AfIDH and dual-specific or NAD⁺-specific IDHs. The key residues identified in MfIDH (Lys340, Ile341, and Ala347) could serve as initial targets .

  • Site-directed mutagenesis: Introduce mutations at these key positions to alter the charge distribution and steric environment of the binding pocket. For switching from NADP⁺ to NAD⁺ preference, this might involve:

    • Introducing negatively charged residues to repel the 2'-phosphate of NADP⁺

    • Removing positively charged residues that interact favorably with this phosphate

    • Modifying the size of the binding pocket to disfavor the larger NADP⁺ molecule

  • Chimeric approaches: Following the example of the clasp domain swapping experiments , entire binding regions could be swapped between AfIDH and IDHs with different specificities.

  • Directed evolution: Combine rational design with directed evolution techniques to screen for variants with altered cofactor preferences.

The success of such engineering efforts would likely be evaluated through kinetic analyses comparing the catalytic efficiency (kcat/Km) with each cofactor, similar to the analysis performed for MfIDH, which showed only a 5-fold higher specificity for NAD⁺ compared to NADP⁺ .

What are the best experimental approaches to study the refolding kinetics of thermostable AfIDH?

Studying the refolding kinetics of thermostable AfIDH would require specialized approaches due to its hyperthermophilic nature. Based on methods used for other archaeal enzymes, the following experimental approaches would be valuable:

Drawing from the experience with H. volcanii IDH refolding , particular attention should be paid to the effects of divalent cations (Mg²⁺), EDTA, and salt concentration on the refolding process.

How can molecular dynamics simulations provide insights into AfIDH thermostability mechanisms?

Molecular dynamics (MD) simulations offer powerful computational approaches to investigate the atomic-level mechanisms underlying AfIDH thermostability. While not explicitly mentioned in the search results, the following strategies would be valuable for researchers:

These simulations would complement experimental studies and could guide rational design efforts to further enhance thermostability or adapt the enzyme for specific biotechnological applications.

How does AfIDH compare to IDHs from other extremophiles in terms of structure and catalytic properties?

AfIDH shares similarities with other extremophilic IDHs but also exhibits distinctive features:

Structural Comparisons:

  • Thermophilic adaptations: AfIDH has common and unique heat adaptive traits compared to hyperthermophilic IDHs from Aeropyrum pernix (ApIDH) and Thermotoga maritima (TmIDH) . While details aren't specific in the search results, these likely include specialized ionic networks and strategic placement of stabilizing interactions.

  • Oligomeric state: AfIDH, like many bacterial IDHs, appears to be dimeric , which contrasts with the monomeric structure of some other IDHs like Chlorobium limicola IDH (80 kDa) .

  • Domain organization: The clasp domain in AfIDH plays a crucial role in thermostability , suggesting that domain architecture and interdomain interactions are important for adaptation to extreme environments.

Catalytic Properties:
Based on data from other extremophilic IDHs, we can infer:

  • Cofactor preference: AfIDH likely maintains NADP⁺ specificity, unlike some IDHs that have evolved dual specificity (like MfIDH) or altered cofactor preference.

  • Temperature optima: The optimal temperature for AfIDH activity is likely much higher than mesophilic counterparts, given its high melting temperature (98.5°C) , compared to enzymes like MfIDH which displayed maximal activity at 60°C .

  • Metal ion requirements: Like other IDHs, AfIDH likely requires divalent cations (Mg²⁺ or Mn²⁺) for activity, as observed in IDHs from M. flagellatus and C. Micrarchaeum harzensis .

OrganismEnzymeOligomeric StateCofactor SpecificityTemperature OptimumNotable Features
A. fulgidusAfIDHDimericNADP⁺High (likely >75°C)Tm = 98.5°C, unique ionic networks
M. flagellatusMfIDHDimeric (90 kDa)Dual (NAD⁺/NADP⁺)60°CRetains 50% activity after 1h at 75°C
C. limicolaClIDHMonomeric (80 kDa)NADP⁺Not specifiedFunctions in CO₂ fixation
C. MicrarchaeumMhIDHNot specifiedNADP⁺Not specifiedLow affinity for NADP⁺
H. volcaniiHvIDHNot specifiedNADP⁺Not specifiedRequires high salt for stability

What evolutionary insights can be gained from comparing AfIDH sequences with those from mesophilic and psychrophilic organisms?

Comparative sequence analysis of AfIDH with homologs from mesophilic and psychrophilic organisms can provide valuable evolutionary insights:

  • Adaptive signatures: By identifying residues that are conserved in thermophiles but differ in mesophiles or psychrophiles, researchers can pinpoint the molecular determinants of thermal adaptation. The unique ionic networks and aromatic clusters in AfIDH likely represent such adaptations.

  • Evolutionary trajectory: Sequence comparison across the temperature spectrum (psychrophilic, mesophilic, thermophilic, hyperthermophilic) can reveal the evolutionary pathway and adaptive strategies employed by IDHs to function at different temperature ranges.

  • Ancestral reconstruction: Phylogenetic analysis combined with ancestral sequence reconstruction could reveal whether the thermophilic or mesophilic state is ancestral, providing insights into the evolutionary history of IDHs.

  • Coevolution patterns: Analysis of co-evolving residues might identify networks of amino acids that work together to maintain protein stability and function at high temperatures. This could be particularly relevant for the inter-domain ionic networks identified in AfIDH .

  • Domain-specific adaptation: The importance of the clasp domain in AfIDH thermostability suggests that different domains might evolve at different rates or under different selective pressures. Domain-specific sequence analysis could reveal these patterns.

  • Horizontal gene transfer (HGT): Unexpected phylogenetic relationships might indicate HGT events between thermophilic and mesophilic organisms, potentially explaining some unusual features of certain IDHs.

Such comparative analyses could inform protein engineering efforts and provide fundamental insights into the molecular mechanisms of protein adaptation to extreme environments.

What is the significance of thermostable IDHs like AfIDH in understanding carbon metabolism in hyperthermophilic archaea?

Thermostable IDHs like AfIDH play crucial roles in understanding carbon metabolism in hyperthermophilic archaea, offering insights into:

  • Metabolic pathway functioning at high temperatures: IDH catalyzes a key step in the tricarboxylic acid (TCA) cycle. The properties of AfIDH provide clues about how central carbon metabolism functions under extreme thermal conditions. The high thermostability (Tm = 98.5°C) ensures that this critical metabolic function remains operational at the high temperatures where A. fulgidus thrives.

  • Directionality of carbon flow: While many IDHs primarily function in the oxidative direction (isocitrate to α-ketoglutarate), some organisms use IDH in reverse for carbon fixation through the reductive TCA cycle, as seen in Chlorobium limicola . Understanding the catalytic properties of AfIDH could reveal whether it participates in similar carbon fixation pathways in A. fulgidus.

  • Metabolic regulation: The response of AfIDH to metabolic intermediates could provide insights into regulation of carbon flux in hyperthermophiles. For instance, some IDHs are inhibited by specific metabolites, such as oxaloacetate inhibiting ClIDH in the carboxylation direction or ATP inhibiting NADP⁺-linked activity in MfIDH .

  • Evolutionary adaptation of central metabolism: The similarities and differences between AfIDH and homologs from mesophilic organisms reflect evolutionary adaptations in central metabolism. These adaptations ensure proper balance between anabolic and catabolic processes under extreme conditions.

  • Energy conservation strategies: The cofactor specificity of AfIDH (likely NADP⁺-specific) provides insights into how hyperthermophilic archaea balance their redox metabolism and energy conservation strategies. NADPH generation is crucial for biosynthetic reactions and maintaining redox homeostasis, particularly important under the oxidative stress that can accompany high-temperature environments.

Understanding these aspects of carbon metabolism in hyperthermophiles not only expands our knowledge of microbial physiology under extreme conditions but also provides potential applications in biotechnology, such as the development of thermostable biocatalysts for industrial processes.

What are the best storage conditions to maintain long-term stability of purified recombinant AfIDH?

While the search results don't provide specific storage conditions for AfIDH, optimal conditions can be inferred from general protein storage practices and approaches used for other thermostable and archaeal enzymes:

  • Temperature considerations:

    • Despite its thermostability, AfIDH should be stored at low temperatures (likely -20°C or -80°C for long-term storage) to minimize chemical degradation processes

    • For working stocks, 4°C might be suitable for short periods, given the enzyme's high stability

  • Buffer composition:

    • Based on storage conditions for other IDHs, a buffer containing 50 mM Tris-HCl (pH 7.5-8.0) with 10% glycerol would likely be appropriate

    • The addition of reducing agents (e.g., 1-5 mM DTT or β-mercaptoethanol) may help prevent oxidation of cysteine residues

    • For A. fulgidus, which is both thermophilic and moderately halophilic, the addition of moderate salt concentrations (e.g., 0.5-1 M NaCl) might enhance stability

  • Cryoprotectants:

    • Glycerol at 20-50% concentration for frozen storage

    • Alternative cryoprotectants like PEG or trehalose could also be effective

  • Stability enhancers:

    • Divalent cations (Mg²⁺ or Mn²⁺) at low concentrations (1-5 mM) might enhance stability by stabilizing the native conformation

    • Enzyme stabilizers such as BSA (0.1-1 mg/mL) might prevent surface denaturation and adsorption losses

  • Storage format:

    • Small aliquots to avoid repeated freeze-thaw cycles

    • Snap freezing in liquid nitrogen before transferring to -80°C storage

Given AfIDH's exceptional thermal stability (Tm = 98.5°C) , it would likely exhibit better storage stability than mesophilic homologs, but preventing chemical degradation processes (oxidation, deamidation, etc.) would still be important for long-term storage.

How can AfIDH be immobilized for biocatalytic applications while maintaining its thermostability?

Immobilization of AfIDH for biocatalytic applications would ideally preserve its remarkable thermostability while providing operational advantages like reusability. While not specifically addressed in the search results, the following approaches would be suitable:

  • Covalent binding to solid supports:

    • Attachment to epoxy-activated supports via lysine residues

    • Glutaraldehyde cross-linking to amino-functionalized matrices

    • These methods form stable covalent bonds that can withstand high temperatures

  • Entrapment in thermostable matrices:

    • Silica sol-gel entrapment, which creates a thermally stable matrix

    • Inclusion in inorganic materials like clay minerals or hydrotalcites

    • These matrices can withstand the high temperatures at which AfIDH operates optimally

  • Affinity immobilization:

    • If AfIDH is expressed with affinity tags, immobilization on appropriate affinity resins

    • This approach allows oriented immobilization, potentially preserving activity better

  • Cross-linked enzyme aggregates (CLEAs):

    • Formation of enzyme aggregates followed by chemical cross-linking

    • This method eliminates the need for a carrier and can enhance thermostability

  • Multi-point attachment strategies:

    • Maximizing the number of attachment points to prevent thermal denaturation

    • This approach can further enhance the already impressive thermostability of AfIDH

For each immobilization method, the following parameters should be optimized:

  • pH and ionic strength during immobilization

  • Enzyme loading

  • Cross-linking density (if applicable)

  • Support particle size and porosity

After immobilization, the thermostability of AfIDH should be reassessed, as immobilization often alters the temperature optimum and stability profile. Ideally, immobilization would maintain or even enhance the native thermostability of AfIDH (Tm = 98.5°C) while improving operational stability for repeated use in biocatalytic applications.

What are the most promising biotechnological applications for thermostable AfIDH?

Thermostable AfIDH offers several promising biotechnological applications leveraging its exceptional stability and catalytic properties:

  • Biocatalysis at elevated temperatures:

    • Synthesis of α-ketoglutarate and related compounds under thermophilic conditions

    • High-temperature processes benefit from increased reaction rates, reduced contamination risk, and improved substrate solubility

    • The reverse reaction (carboxylation) could potentially be utilized for carbon fixation or specialty chemical synthesis

  • NADPH regeneration systems:

    • As an NADP⁺-dependent enzyme, AfIDH could serve as an efficient thermostable NADPH regeneration catalyst

    • This would support other NADPH-dependent biocatalytic processes requiring reducing equivalents

    • The thermostability allows coupling with other thermophilic enzymes in multi-enzyme cascades

  • Biosensors and analytical applications:

    • Development of thermostable biosensors for isocitrate detection

    • Applications in food quality control, clinical diagnostics, and environmental monitoring

    • The high stability would enable robust sensor systems with extended shelf-life and operational life

  • Structural biology research platform:

    • Model system for studying protein thermostability mechanisms

    • Template for rational design of thermostable variants of other enzymes

    • Platform for investigating structure-function relationships in metabolic enzymes

  • Educational and research tool:

    • Demonstration enzyme for teaching concepts of thermostability

    • Reference enzyme for comparing properties of mesophilic, thermophilic, and psychrophilic proteins

    • Model for computational studies on protein dynamics at extreme temperatures

The unique inter-domain ionic networks and aromatic clusters that contribute to AfIDH thermostability could also inform the design of other thermostable proteins for biotechnological applications. The principles derived from AfIDH's structure-stability relationships could be broadly applicable to protein engineering efforts aimed at enhancing thermal resistance.

How can I address low expression levels or inclusion body formation when producing recombinant AfIDH?

Low expression levels and inclusion body formation are common challenges when expressing archaeal proteins in E. coli. Based on experiences with similar enzymes, the following strategies could address these issues:

  • Optimizing expression conditions:

    • Lower induction temperature (16-25°C instead of 37°C) to slow protein synthesis and improve folding

    • Reduce IPTG concentration (0.1-0.5 mM instead of 1 mM) to decrease expression rate

    • Use rich media like Terrific Broth or auto-induction media for improved cell density and protein yield

    • Extend post-induction incubation time (overnight at lower temperatures)

  • Addressing inclusion body formation:

    • If inclusion bodies form (as observed with H. volcanii IDH ), develop a refolding protocol

    • Solubilize inclusion bodies with 6-8 M urea or guanidinium hydrochloride

    • Refold by gradual dilution into a buffer containing EDTA, MgCl₂, and appropriate salt (e.g., 3 M NaCl for halophilic enzymes)

    • Allow sufficient time for refolding (several hours at room temperature)

  • Expression system modifications:

    • Use specialized E. coli strains like Rosetta (for rare codon usage) or Origami (for disulfide bond formation)

    • Co-express molecular chaperones (GroEL/ES, DnaK/J) to assist protein folding

    • Try fusion tags that enhance solubility (e.g., SUMO, MBP, or TrxA) instead of simple His-tags

    • Consider alternative expression hosts (e.g., Bacillus species or yeast systems)

  • Genetic optimization:

    • Codon optimization for E. coli expression

    • Remove rare codons or unfavorable mRNA secondary structures

    • Consider expressing a truncated or modified version if specific regions cause aggregation

  • Scale-up strategies:

    • Implement fed-batch cultivation to achieve higher cell densities

    • Optimize media composition based on cell requirements

    • Monitor dissolved oxygen and pH during cultivation

These approaches should be tested systematically, potentially using small-scale expression trials before scaling up to larger volumes once optimal conditions are identified.

What are the common pitfalls in kinetic analysis of AfIDH and how can they be avoided?

Kinetic analysis of thermostable enzymes like AfIDH presents several challenges. While specific pitfalls for AfIDH aren't detailed in the search results, common issues and solutions can be inferred from studies of similar enzymes:

  • Temperature-related challenges:

    • Pitfall: Conducting assays at temperatures below the enzyme's optimum

    • Solution: Use temperature-controlled spectrophotometers and preheated buffers to maintain consistent high temperatures during measurement

    • Pitfall: Temperature gradients within the reaction mixture

    • Solution: Ensure thorough mixing and temperature equilibration before initiating the reaction

  • Substrate stability issues:

    • Pitfall: Degradation of isocitrate or NADP⁺ at high temperatures

    • Solution: Prepare fresh substrate solutions for each experiment and determine their stability under assay conditions

    • Pitfall: Spontaneous decarboxylation of isocitrate at high temperatures

    • Solution: Use appropriate controls to account for non-enzymatic reactions

  • Cofactor specificity analysis:

    • Pitfall: Contamination of NADP⁺ with NAD⁺ or vice versa

    • Solution: Use high-purity cofactors and include proper controls

    • Pitfall: Incorrect determination of specificity constants (kcat/Km)

    • Solution: Ensure measurements at sufficiently low substrate concentrations to accurately determine Km

  • Metal ion dependence:

    • Pitfall: Variation in activity due to inconsistent metal ion concentration

    • Solution: Carefully control the concentration of divalent cations (Mg²⁺ or Mn²⁺) and include EDTA treatment steps if necessary

    • Pitfall: Interference from traces of other metals

    • Solution: Use high-purity reagents and consider metal speciation at high temperatures

  • Data analysis errors:

    • Pitfall: Inappropriate application of Michaelis-Menten kinetics

    • Solution: Verify that the enzyme follows Michaelis-Menten kinetics and consider alternative models if necessary

    • Pitfall: Neglecting to account for substrate or product inhibition

    • Solution: Design experiments to detect and quantify any inhibition effects

  • pH effects:

    • Pitfall: Failing to account for pH changes with temperature (ΔpKa/ΔT)

    • Solution: Use temperature-compensated pH measurements and buffers with minimal temperature dependence

Careful experimental design, appropriate controls, and awareness of these potential pitfalls will lead to more reliable kinetic characterization of AfIDH.

How can I distinguish between effects caused by the His-tag and intrinsic properties of AfIDH?

Distinguishing between His-tag effects and intrinsic properties of AfIDH is crucial for accurate characterization. While not specifically addressed for AfIDH in the search results, the following approaches would be effective:

  • Comparative analysis with tag-removed enzyme:

    • Express the enzyme with a cleavable His-tag

    • Purify both His-tagged and tag-removed versions

    • Compare key properties (activity, stability, structure) between the two forms

    • This approach directly identifies tag-related effects

  • Alternative tag positions:

    • Create constructs with N-terminal versus C-terminal His-tags

    • Compare the properties of both versions

    • Significant differences would suggest tag position-dependent effects

  • Control experiments with different tags:

    • Express AfIDH with alternative tags (e.g., FLAG, Strep, GST)

    • Compare properties across differently tagged versions

    • Consistent properties across different tags likely represent intrinsic enzyme characteristics

  • Structural analysis approaches:

    • Perform circular dichroism (CD) spectroscopy on tagged and untagged versions

    • Use differential scanning calorimetry (DSC) to compare thermal unfolding profiles

    • Conduct limited proteolysis to identify any structural differences

  • Kinetic parameter comparison:

    • Determine detailed kinetic parameters (Km, kcat, substrate specificity) for tagged and untagged versions

    • Compare with literature values for native enzyme if available

    • Significant differences in kinetic parameters could indicate tag interference with substrate binding or catalysis

  • Native enzyme comparison:

    • If possible, purify native AfIDH from A. fulgidus cells

    • Compare with recombinant versions to identify any expression system artifacts

    • This approach, while challenging, provides the most definitive reference point

In the case of MfIDH, researchers noted that "The native and the recombinant 6x-His-tagged MfIDHs have essentially the same biochemical characteristics" , suggesting that for some IDHs, the His-tag may have minimal impact on fundamental properties.

What are promising approaches for crystallizing AfIDH for high-resolution structural studies?

High-resolution structural studies of AfIDH would provide valuable insights into its thermostability mechanisms and catalytic properties. While specific crystallization conditions for AfIDH aren't provided in the search results, the following approaches would be promising:

  • Optimization of protein sample:

    • Ensure high purity (>95% by SDS-PAGE)

    • Confirm monodispersity by dynamic light scattering

    • Test both His-tagged and tag-cleaved versions

    • Consider surface entropy reduction mutations to promote crystal contacts

  • Crystallization screening strategies:

    • Perform initial sparse matrix screening at multiple temperatures (4°C, 20°C, 37°C)

    • Use both vapor diffusion (hanging and sitting drop) and batch methods

    • Include substrate, cofactor, or substrate analogs to stabilize the active site

    • Test crystallization in the presence of different divalent cations (Mg²⁺, Mn²⁺)

  • Thermophile-specific considerations:

    • Include moderate concentrations of salt in crystallization buffers

    • Try higher temperatures for crystallization setup (30-45°C)

    • Consider oil-based methods to slow vapor diffusion at higher temperatures

  • AfIDH-specific approaches:

    • Based on the solved structure at 2.5 Å , optimize conditions to obtain higher resolution

    • Try co-crystallization with the clasp domain from E. coli IDH (for comparative studies)

    • Attempt crystallization of AfIDH in different conformational states using substrate analogs

  • Advanced techniques if initial screens fail:

    • Surface methylation or other chemical modifications to enhance crystallizability

    • Crystallization chaperones (e.g., antibody fragments or designed binding proteins)

    • In situ proteolysis during crystallization

    • Lipidic cubic phase crystallization as an alternative approach

  • Data collection considerations:

    • Cryoprotection optimization to minimize ice formation

    • Room-temperature data collection to avoid potential artifacts from cryocooling

    • Consideration of micro-focus beamlines for small crystals

The resultant high-resolution structures would provide detailed insights into the unique features of AfIDH identified previously, such as the inter-domain ionic networks and aromatic clusters contributing to thermostability .

How might directed evolution be applied to enhance specific properties of AfIDH?

Directed evolution offers powerful approaches to enhance specific properties of AfIDH for research or biotechnological applications. While not mentioned specifically for AfIDH in the search results, the following strategies would be effective:

  • Enhancing thermostability further:

    • Random mutagenesis libraries screened at temperatures exceeding the current stability limits

    • Selection based on residual activity after extreme temperature challenges

    • Focus on regions identified as important for thermostability (clasp domain, inter-domain contacts)

  • Altering cofactor specificity:

    • Random or focused mutagenesis of the cofactor binding pocket

    • Screening for variants with altered NAD⁺/NADP⁺ preference

    • Target positions corresponding to the key residues identified in MfIDH (Lys340, Ile341, Ala347)

  • Modifying substrate specificity:

    • Error-prone PCR targeting the substrate binding pocket

    • Activity screening with alternative substrates (e.g., homoisocitrate)

    • Selection for variants that can accept bulkier or industrially relevant substrates

  • Improving catalytic efficiency:

    • Combinatorial site-saturation mutagenesis of residues near the active site

    • Selection for variants with enhanced kcat/Km values

    • High-throughput activity assays using colorimetric or fluorescent readouts

  • Increasing solvent tolerance:

    • Random mutagenesis combined with screening in the presence of organic solvents

    • Gradual increase in solvent concentration to select progressively more tolerant variants

    • Focus on surface residues that might interact with solvent molecules

  • Screening methods and platforms:

    • Microplate-based activity assays for moderate-throughput screening

    • Cell-based selections using auxotrophy complementation

    • Droplet microfluidics for ultra-high-throughput screening

    • FACS-based screening if activity can be coupled to a fluorescent output

  • Computational guidance:

    • Use computational tools to predict beneficial mutations

    • Machine learning approaches to guide library design

    • Molecular dynamics simulations to identify flexible regions that might benefit from stabilization

Successful directed evolution campaigns would likely combine multiple rounds of diversification and selection, potentially with iterative focusing on promising regions identified in early rounds.

What new insights could be gained from studying AfIDH in the context of metabolic engineering?

Studying AfIDH in the context of metabolic engineering could provide several valuable insights:

  • Thermostable metabolic pathways:

    • AfIDH could serve as a key component for designing thermostable variants of the TCA cycle

    • Understanding how AfIDH interfaces with other metabolic enzymes could guide the engineering of complete thermophilic pathways

    • This could enable the development of high-temperature fermentation processes with improved kinetics and reduced contamination risk

  • NADPH regeneration systems:

    • Incorporating AfIDH into metabolic pathways as a thermostable NADPH regeneration node

    • Optimizing the balance between carbon flux and redox cofactor regeneration at elevated temperatures

    • Engineering regulatory mechanisms to control NADPH production in response to cellular needs

  • Carbon fixation enhancement:

    • Investigating whether AfIDH can be engineered to favor the carboxylation reaction, similar to IDH from Chlorobium limicola

    • Developing thermostable carbon fixation pathways based on the reverse TCA cycle

    • This could lead to new approaches for CO₂ capture and conversion at elevated temperatures

  • Metabolic pathway optimization:

    • Understanding the kinetic parameters and regulatory properties of AfIDH to accurately model its behavior in engineered pathways

    • Identifying potential bottlenecks or regulatory constraints when integrating AfIDH into heterologous pathways

    • Developing strategies to overcome these limitations through protein engineering or pathway redesign

  • Synthetic biology applications:

    • Using AfIDH as a building block for synthetic metabolic modules functioning at high temperatures

    • Exploring novel pathway architectures that leverage the unique properties of thermostable enzymes

    • Developing orthogonal metabolic systems that function under conditions where native metabolism is inhibited

  • Industrial biotechnology insights:

    • Evaluating the performance of AfIDH-containing pathways under industrially relevant conditions

    • Understanding the trade-offs between enzyme thermostability, catalytic efficiency, and metabolic flux

    • Developing strategies to optimize yield, titer, and productivity in thermophilic bioprocesses

These investigations would not only advance our understanding of thermophilic metabolism but could also lead to practical applications in metabolic engineering for biofuel production, specialty chemical synthesis, and other biotechnological processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.